PuSH - Publikationsserver des Helmholtz Zentrums München

74 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
41.
Ronchi, C.L.* et al.: Genetic landscape of sporadic unilateral adrenocortical adenomas without PRKACA p.Leu206Arg mutation. J. Clin. Endocrinol. Metab. 101, 3526-3538 (2016)
42.
Xu, G.* et al.: Liver and muscle contribute differently to the plasma acylcarnitine pool during fasting and exercise in humans. J. Clin. Endocrinol. Metab. 101, 5044-5052 (2016)
43.
Kovarova, M.* et al.: The genetic variant I148M in PNPLA3 is associated with increased hepatic retinyl-palmitate storage in humans. J. Clin. Endocrinol. Metab. 100, E1568–E1574 (2015)
44.
Lichtenauer, U.D.* et al.: Frequency and clinical correlates of somatic Ying Yang 1 mutations in sporadic insulinomas. J. Clin. Endocrinol. Metab. 100, E776-E782 (2015)
45.
Linder, K. et al.: Gestational diabetes impairs human fetal postprandial brain activity. J. Clin. Endocrinol. Metab. 100, 4029-4036 (2015)
46.
47.
Rottenkolber, M.* et al.: The diabetes risk phenotype of young women with recent gestational diabetes. J. Clin. Endocrinol. Metab. 100, E910-E918 (2015)
48.
Bidlingmaier, M. et al.: Reference intervals for Insulin-like Growth Factor-1 (IGF-1) from birth to senescence: Results from a multicenter study using a new automated chemiluminescence IGF-1 immunoassay conforming to recent international recommendations. J. Clin. Endocrinol. Metab. 9, 1712-1721 (2014)
49.
Friedrich, N.* et al.: Age- and sex-specific reference intervals across life span for Insulin-like Growth Factor Binding Protein 3 (IGFBP-3) and the IGF-i to IGFBP-3 ratio measured by new automated chemiluminescence assays. J. Clin. Endocrinol. Metab. 99, 1675-1686 (2014)
50.
Iwen, K.A.* et al.: Intranasal insulin suppresses systemic but not subcutaneous lipolysis in healthy humans. J. Clin. Endocrinol. Metab. 99, E246-E251 (2014)
51.
Johar, H. et al.: Blunted diurnal cortisol pattern is associated with frailty: A cross-sectional study of 745 participants aged 65 to 90 years. J. Clin. Endocrinol. Metab. 99, E464-E468 (2014)
52.
Krinninger, P. et al.: Peripheral monocytes of obese women display increased chemokine receptor expression and migration capacity. J. Clin. Endocrinol. Metab. 99, 2500-2509:jc20132611 (2014)
53.
Mook-Kanamori, D.O.* et al.: 1,5-anhydroglucitol in saliva is a noninvasive marker of short-term glycemic control. J. Clin. Endocrinol. Metab. 99, E479-E483 (2014)
54.
Fischer, E.* et al.: Aldosterone excess impairs first phase insulin secretion in primary aldosteronism. J. Clin. Endocrinol. Metab. 98, 2513-2520 (2013)
55.
Heni, M.* et al.: Genetic variation in NR1H4 encoding the bile acid receptor FXR determines fasting glucose and free fatty acid levels in humans. J. Clin. Endocrinol. Metab. 98, E1224-E1229 (2013)
56.
Karakas, M.* et al.: Low levels of serum 25-hydroxyvitamin D are associated with increased risk of myocardial infarction, especially in women: Results from the MONICA/KORA Augsburg case-cohort study. J. Clin. Endocrinol. Metab. 98, 272-280 (2013)
57.
Tong, J.* et al.: Physiologic concentrations of exogenously infused ghrelin reduces insulin secretion without affecting insulin sensitivity in healthy humans. J. Clin. Endocrinol. Metab. 98, 2536-2543 (2013)
58.
Wolf, M.* et al.: Production and release of acylcarnitines by primary myotubes reflect the differences in fasting fat oxidation of the donors. J. Clin. Endocrinol. Metab. 98, E1137-E1142 (2013)
59.
Alkemade, A.* et al.: AgRP and NPY expression in the human hypothalamic infundibular nucleus correlate with body mass index, whereas changes in αMSH are related to type 2 diabetes. J. Clin. Endocrinol. Metab. 97, E925-E933 (2012)
60.
Tong, J.* et al.: Ghrelin stimulation of growth hormone isoforms: Parallel secretion of total and 20-kDag growth hormone and relation to insulin sensitivity in healthy humans. J. Clin. Endocrinol. Metab. 97, 3366-3374 (2012)